Beyond the funding round, OpenAI has announced strategic partnerships with both NVIDIA and Amazon. This will involve Amazon Web Services (AWS) running OpenAI models for enterprise customers to "build generative AI applications and agents at production scale." It also names AWS as the exclusive third-party cloud distribution provider for OpenAI Frontier, which is an agentic enterprise platform.
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
。业内人士推荐同城约会作为进阶阅读
GiftGift this article
Что думаешь? Оцени!